Markets:

Overview

News

Currencies

International

Treasuries

Elevation Oncology, Inc. - Common stock (NQ:ELEV)

0.3650 UNCHANGED

Last Price Updated: 4:00 PM EDT, Jul 22, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Elevation Oncology, Inc. - Common stock

< Previous 1 2 3 4 5 Next >

This McDonald's Analyst Turns Bearish; Here Are Top 4 Downgrades For Tuesday ↗

June 10, 2025

Via Benzinga

Let's uncover which stocks are experiencing notable gaps during today's session. ↗

June 09, 2025

The market is filled with gapping stocks in Monday's session. Let's discover which stocks are showing gap-ups and gap-downs.

Via Chartmill

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

May 29, 2025

Via Benzinga

Curious about the stocks that are showing activity after the closing bell on Monday? ↗

April 28, 2025

The US market regular session of Monday is over, let's have a look at the top gainers and losers in the after hours session today.

Via Chartmill

Recap: Elevation Oncology Q4 Earnings ↗

March 06, 2024

Via Benzinga

Tesla To $410? Here Are 10 Top Analyst Forecasts For Friday ↗

March 21, 2025

Via Benzinga

Here are the top movers in Thursday's session. ↗

March 20, 2025

Here are the top movers in Thursday's session, showcasing the stocks with significant price changes.

Via Chartmill

Top movers in Thursday's session ↗

March 20, 2025

Intrigued by the market activity in the middle of the day on Thursday? Uncover the key winners and losers of today's session in our insightful analysis.

Via Chartmill

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

March 20, 2025

Via Benzinga

Which stocks are gapping on Thursday? ↗

March 20, 2025

The market is filled with gapping stocks in Thursday's session. Let's discover which stocks are showing gap-ups and gap-downs.

Via Chartmill

Crude Oil Gains Over 1%; US Weekly Jobless Claims Increase ↗

March 20, 2025

Via Benzinga

Elevation Oncology Stops Gastric Cancer Study, Slashes Staff By 70% ↗

March 20, 2025

Elevation Oncology ends EO-3021 development after Phase 1 results, shifts focus to EO-1022, and plans a major workforce reduction to extend funding.

Via Benzinga

Stay updated with the stocks that are on the move in today's pre-market session. ↗

March 20, 2025

Before the opening bell on Thursday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.

Via Chartmill

Dow Gains Over 100 Points; Accenture Shares Plunge After Q2 Results ↗

March 20, 2025

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

March 13, 2025

Via Benzinga

Elevation Oncology: Promising Cancer Therapies Earn Analyst Praise ↗

January 03, 2025

Elevation Oncology's ADCs target CLDN18.2 and HER3, with EO-3021 showing promising Phase 1 results and a $6.6 billion TAM in gastric and pancreatic cancers.

Via Benzinga

This Denali Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top Initiations For Friday ↗

January 03, 2025

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

September 27, 2024

Via Benzinga

S&P 500 Surges Over 2%; Caterpillar Earnings Beat Estimates ↗

August 06, 2024

Via Benzinga

Topics Earnings Stocks

Why Is Penny Stock Elevation Oncology Trading Lower On Tuesday? ↗

August 06, 2024

Elevation Oncology shares dropped after initial data from the Phase 1 trial of EO-3021 showed a 42.8% objective response rate in patients with advanced solid tumors expressing Claudin 18.2. No Grade 4...

Via Benzinga

Crude Oil Moves Higher; Yum! Brands Posts Upbeat Earnings ↗

August 06, 2024

Via Benzinga

Dow Jumps Over 300 Points; US Trade Gap Narrows In June ↗

August 06, 2024

Via Benzinga

Topics Stocks

GeneDx Leads Russell 2000 This Year As It Shifts To More Comprehensive Genetic Testing ↗

July 18, 2024

GeneDx Holdings Corp. (NASDAQ: WGS) has soared 1,101% this year, attributed to its mix shift towards exome/genome testing and record high margins.

Via Benzinga

7 Top Stocks to Buy for Under $10: May 2024 ↗

May 27, 2024

By diversifying your portfolio with top stocks for under $10, you can profit from companies that are just starting their growth stories.

Via InvestorPlace

12 Health Care Stocks Moving In Monday's After-Market Session ↗

May 13, 2024

Via Benzinga

ELEV Stock Earnings: Elevation Oncology Misses EPS for Q1 2024 ↗

May 02, 2024

ELEV stock results show that Elevation Oncology missed analyst estimates for earnings per share the first quarter of 2024.

Via InvestorPlace

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

May 02, 2024

Via Benzinga

7 Top Stocks Under $7 ↗

April 11, 2024

Stocks under $7 have greater potential for substantial gains because they start off with lower valuations. Here are some of the best now.

Via InvestorPlace

5 Healthcare Stocks to Buy for 2024 ↗

April 02, 2024

Healthcare stocks have been some of the top performers in 2024, and thanks to the potential of AI, these names will just keep heating up.

Via InvestorPlace

Topics Artificial Intelligence

ELEV Stock Earnings: Elevation Oncology Beats EPS for Q4 2023 ↗

March 06, 2024

ELEV stock results show that Elevation Oncology beat analyst estimates for earnings per share the fourth quarter of 2023.

Via InvestorPlace

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.